Which statement about Blastocystis testing is not routinely performed in most clinics?

• A. Symptom-based management
• B. Antibiotics not used
• C. PCR-based subtyping is not routinely performed
• D. Culture-based subtyping is standard

Answer: (C)

The main idea is that routine clinical testing for Blastocystis focuses on confirming infection to guide symptom-based management, not on detailed genetic characterization. PCR-based subtyping identifies specific subtypes by amplifying and sequencing genes, but this information rarely changes how a patient is treated or counseled, since there isn’t a consistent, clinically actionable link between subtype and disease severity or response to therapy. Because subtyping by PCR requires specialized equipment, additional costs, and longer turnaround without improving patient outcomes, it isn’t routinely performed in most clinics. In contrast, management decisions are driven by symptoms, and antibiotics are used only when there’s a clear indication for treatment, rather than as a standard approach for all Blastocystis infections. Saying that culture-based subtyping is standard would imply routine use of subtyping from culture, which isn't a standard clinical practice.